Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition

Keyphrases

• Molecular Mechanism 100%
• Reverse Transcriptase 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Inhibition Mechanism 100%
• HIV-1 Reverse Transcriptase 100%
• Polymerization Mechanism 100%
• Drug Therapy 66%
• Anti-HIV Drugs 66%
• New Drugs 33%
• Drug Target 33%
• Protease 33%
• Polymerase 33%
• Virus 33%
• Resistant Strains 33%
• Drug Toxicity 33%
• HIV-1 Infection 33%
• Resistance Development 33%
• Viral Replication 33%
• Vaccine Development 33%
• Unnatural nucleotides 33%
• Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) 33%
• Integrase 33%
• RNase H Activity 33%
• Viral Enzymes 33%
• Nucleoside Analogues 33%
• Reverse Transcriptase Inhibitors 33%
• Polymerase Activity 33%

Medicine and Dentistry

• RNA Directed DNA Polymerase 100%
• Human Immunodeficiency Virus 75%
• Drug Therapy 50%
• Polymerase 50%
• Reverse-Transcriptase Inhibitor 50%
• Anti-Human Immunodeficiency Virus 50%
• Ribonuclease 25%
• Proteinase 25%
• Vaccine Development 25%
• Integrase 25%
• Nonnucleoside Reverse Transcriptase Inhibitor 25%
• Human Immunodeficiency Virus 1 Infection 25%
• Virus Replication 25%
• Drug Toxicity 25%
• Virus 25%
• Nucleoside Analog 25%

Pharmacology, Toxicology and Pharmaceutical Science

• RNA Directed DNA Polymerase 100%
• HIV 75%
• Pharmacotherapy 50%
• Anti-Human Immunodeficiency Virus 50%
• RNA Directed DNA Polymerase Inhibitor 50%
• Ribonuclease 25%
• Proteinase 25%
• Drug Toxicity 25%
• Vaccine Development 25%
• Integrase 25%
• Human Immunodeficiency Virus 1 Infection 25%
• Nonnucleoside Reverse Transcriptase Inhibitor 25%
• Nucleoside Analog 25%